151 related articles for article (PubMed ID: 3267010)
21. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity.
Chastain JE; Pazdernik TL
Int J Immunopharmacol; 1985; 7(6):849-56. PubMed ID: 3908345
[TBL] [Abstract][Full Text] [Related]
22. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
[TBL] [Abstract][Full Text] [Related]
24. Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
House RV; Lauer LD; Murray MJ; Thomas PT; Ehrlich JP; Burleson GR; Dean JH
J Toxicol Environ Health; 1990 Nov; 31(3):203-15. PubMed ID: 1700136
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
[TBL] [Abstract][Full Text] [Related]
26. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
27. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppression without liver induction by subchronic exposure to 2,7-dichlorodibenzo-p-dioxin in adult female B6C3F1 mice.
Holsapple MP; McCay JA; Barnes DW
Toxicol Appl Pharmacol; 1986 May; 83(3):445-55. PubMed ID: 3486501
[TBL] [Abstract][Full Text] [Related]
29. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
30. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
[TBL] [Abstract][Full Text] [Related]
31. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Neubert R; Jacob-Müller U; Stahlmann R; Helge H; Neubert D
Arch Toxicol; 1990; 64(5):345-59. PubMed ID: 2403285
[TBL] [Abstract][Full Text] [Related]
32. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression.
Clark GC; Blank JA; Germolec DR; Luster MI
Mol Pharmacol; 1991 Apr; 39(4):495-501. PubMed ID: 1850092
[TBL] [Abstract][Full Text] [Related]
33. The effect of cadmium on antibody responses to antigens with different cellular requirements.
Blakley BR; Tomar RS
Int J Immunopharmacol; 1986; 8(8):1009-15. PubMed ID: 3492449
[TBL] [Abstract][Full Text] [Related]
34. The effect of acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral antibody production and cell-mediated activities in mice.
Vecchi A; Mantovani A; Sironi M; Luini W; Spreafico F; Garattini S
Arch Toxicol Suppl; 1980; 4():163-5. PubMed ID: 6933896
[TBL] [Abstract][Full Text] [Related]
35. T cell receptor transgenic mice provide novel insights into understanding cellular targets of TCDD: suppression of antibody production, but not the response of CD8(+) T cells, during infection with influenza virus.
Mitchell KA; Lawrence BP
Toxicol Appl Pharmacol; 2003 Nov; 192(3):275-86. PubMed ID: 14575645
[TBL] [Abstract][Full Text] [Related]
36. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
37. Immunotoxicologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rabbits.
Sharma RP; Kociba RJ; Gehring PJ
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):321-8. PubMed ID: 6520734
[TBL] [Abstract][Full Text] [Related]
38. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro.
Thurmond LM; House RV; Lauer LD; Dean JH
Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829
[TBL] [Abstract][Full Text] [Related]
39. T cell-derived IL-5 production is a sensitive target of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Inouye K; Pan X; Imai N; Ito T; Takei T; Tohyama C; Nohara K
Chemosphere; 2005 Aug; 60(7):907-13. PubMed ID: 15992597
[TBL] [Abstract][Full Text] [Related]
40. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment in vivo on thymocyte functions in mice after activation in vitro.
Lundberg K; Dencker L; Grönvik KO
Int J Immunopharmacol; 1990; 12(4):459-66. PubMed ID: 1975249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
